Skip to main content

Table 3 Echocardiographic left ventricular functional data

From: Rutin administration attenuates myocardial dysfunction in diabetic rats

Parameters C (n = 14) C-R (n = 14) DM (n = 16) DM-R (n = 16)
FS (%) 54.1 ± 5.2 52.5 ± 2.87 48.7 ± 3.4* 52.6 ± 4.2§
PWSV (mm/s) 44.5 ± 4.6 44.3 ± 3.54 35.5 ± 5.4* 42.7 ± 4.6§
E (cm/s) 74.1 ± 11.7 66.6 ± 10.2 75.1 ± 14.3 79.8 ± 12.2#
A (cm/s) 52.9 ± 11.3 45.5 ± 8.82 48.1 ± 18.1 63.1 ± 21.8
E/A 1.43 ± 0.23 1.51 ± 0.31 1.77 ± 0.82 1.36 ± 0.34§
  1. Data are expressed as mean ± standard deviation. One-way ANOVA in a factorial design 2 × 2 and Tukey’s post hoc test.
  2. C untreated rats, C-R rutin-treated rats, DM untreated diabetic rats, DM-R rutin-treated diabetic rats, FS endocardial fractional shortening, PWSV posterior wall shortening velocity, E early diastolic mitral inflow velocity, A late diastolic mitral inflow velocity, E/A E/A ratio.
  3. * p < 0.05 vs C; #p < 0.05 vs C-R; §p < 0.05 vs DM.